Literature DB >> 18195302

Tracing uncontrolled asthma in family practice using a mailed asthma control questionnaire.

Lotte van den Nieuwenhof1, Tjard Schermer, Marianne Heins, Joke Grootens, Petra Eysink, Ben Bottema, Chris van Weel, Patrick Bindels.   

Abstract

PURPOSE: A substantial proportion of adult patients with asthma have inadequately controlled symptoms despite the availability of effective treatment. The Asthma Control Questionnaire (ACQ) can be used to discriminate between asthma patients with well- and suboptimally controlled asthma symptoms. The objective of this study was to investigate whether a postal mailing of the ACQ can be used to identify asthma patients with suboptimal symptom control in family practice.
METHODS: In this observational study, we sent 434 asthma patients from 6 Dutch family practices an ACQ by mail to measure control of their asthma symptoms. Both respondents and nonrespondents were characterized by information gathered from their medical records. Patients with an ACQ sum score (total score) of greater than 3 were considered to have suboptimally controlled asthma symptoms.
RESULTS: The response rate was 77%. Respondents were more likely than non-respondents to be female and to use asthma medication. The mean ACQ sum score of the respondents was 5.2. Of this group, 53.4% (95% confidence interval, 48.0%-58.8%) had suboptimally controlled asthma symptoms. Of the 168 respondents who had not visited their family physician in the 2 years before the study, 42.9% (95% confidence interval, 35.4%-50.4%) had inadequate asthma symptom control.
CONCLUSIONS: Our results show that a postal mailing of the ACQ is an effective approach for tracing asthma patients who need medical attention. It also traces patients who would otherwise not have consulted their family physician. The ACQ seems to be a useful starting point for health care professionals in family practice to improve the level of asthma symptom control in their patient population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18195302      PMCID: PMC2203381          DOI: 10.1370/afm.776

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  24 in total

Review 1.  Asthma control: where do we fail?

Authors:  J C Kips; R A Pauwels
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

2.  Measuring asthma control. Clinic questionnaire or daily diary?

Authors:  E F Juniper; P M O'Byrne; P J Ferrie; D R King; J N Roberts
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

3.  Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use?

Authors:  E F Juniper; P M O'Byrne; J N Roberts
Journal:  Respir Med       Date:  2001-05       Impact factor: 3.415

4.  Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response.

Authors:  P Bakke; A Gulsvik; P Lilleng; O Overå; R Hanoa; G E Eide
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

5.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

6.  How should we quantify asthma control? A proposal.

Authors:  Louis-Philippe Boulet; Véronique Boulet; Joanne Milot
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

7.  Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study.

Authors:  Lotte van den Nieuwenhof; Tjard Schermer; Petra Eysink; Eric Halet; Chris van Weel; Patrick Bindels; Ben Bottema
Journal:  Fam Pract       Date:  2006-07-31       Impact factor: 2.267

8.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

Authors:  J K Sont; L N Willems; E H Bel; J H van Krieken; J P Vandenbroucke; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

9.  Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study.

Authors:  Christopher K W Lai; Teresita S De Guia; You-Young Kim; Sow-Hsong Kuo; Amartya Mukhopadhyay; Joan B Soriano; Pham Long Trung; Nan Shan Zhong; Norzila Zainudin; B M Z Zainudin
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

10.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Authors:  Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

View more
  4 in total

1.  Validation of the AQLQ12+ among adolescents and adults with persistent asthma.

Authors:  Kathleen W Wyrwich; Andrea M Ireland; Prakash Navaratnam; Hendrik Nolte; Davis F Gates
Journal:  Qual Life Res       Date:  2010-12-24       Impact factor: 4.147

2.  Putative Role of Cardio Metabolic Risk Among Poorly Controlled Asthmatics in South Indian Population.

Authors:  Murugaiyan Sathish Babu; K P Sreesoorya; Surendra K Menon; Subiman Saha; A R Srinivasan; S Arul Vijaya Vani; R Reeta; V Kuzhandai Velu
Journal:  Indian J Clin Biochem       Date:  2016-07-22

3.  Uncontrolled asthma: assessing quality of life and productivity of children and their caregivers using a cross-sectional Internet-based survey.

Authors:  Bonnie B Dean; Brian C Calimlim; Patricia Sacco; Daniel Aguilar; Robert Maykut; David Tinkelman
Journal:  Health Qual Life Outcomes       Date:  2010-09-08       Impact factor: 3.186

4.  Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment.

Authors:  Persijn J Honkoop; Rik J B Loymans; Evelien H Termeer; Jiska B Snoeck-Stroband; Moira J Bakker; Willem J J Assendelft; Peter J Sterk; Gerben Ter Riet; Tjard R J Schermer; Jacob K Sont
Journal:  BMC Pulm Med       Date:  2011-11-24       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.